Gantzert Investment Co. LLC ADV boosted its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 1.1% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 33,865 shares of the pharmacy operator’s stock after buying an additional 365 shares during the quarter. Walgreens Boots Alliance comprises approximately 2.2% of Gantzert Investment Co. LLC ADV’s investment portfolio, making the stock its 22nd largest holding. Gantzert Investment Co. LLC ADV’s holdings in Walgreens Boots Alliance were worth $2,143,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Oregon Public Employees Retirement Fund raised its position in shares of Walgreens Boots Alliance by 12,422.1% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 34,807,507 shares of the pharmacy operator’s stock worth $509,000 after acquiring an additional 34,529,539 shares in the last quarter. Bank of New York Mellon Corp raised its position in shares of Walgreens Boots Alliance by 71,970.7% in the 3rd quarter. Bank of New York Mellon Corp now owns 11,640,855 shares of the pharmacy operator’s stock worth $848,617,000 after acquiring an additional 11,624,703 shares in the last quarter. Norges Bank bought a new position in shares of Walgreens Boots Alliance in the 4th quarter worth about $589,781,000. Boston Partners raised its position in shares of Walgreens Boots Alliance by 3,449.3% in the 4th quarter. Boston Partners now owns 3,973,944 shares of the pharmacy operator’s stock worth $271,540,000 after acquiring an additional 3,861,981 shares in the last quarter. Finally, Morgan Stanley raised its position in shares of Walgreens Boots Alliance by 49.8% in the 3rd quarter. Morgan Stanley now owns 6,248,967 shares of the pharmacy operator’s stock worth $455,550,000 after acquiring an additional 2,077,270 shares in the last quarter. 65.05% of the stock is currently owned by hedge funds and other institutional investors.
Several research analysts have recently weighed in on WBA shares. BidaskClub lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Wednesday, March 6th. UBS Group decreased their target price on Walgreens Boots Alliance from $70.00 to $65.00 and set a “sell” rating for the company in a research report on Monday, March 4th. Cowen reaffirmed a “hold” rating and issued a $66.00 target price on shares of Walgreens Boots Alliance in a research report on Sunday, March 31st. Barclays decreased their target price on Walgreens Boots Alliance from $78.00 to $60.00 and set an “equal weight” rating for the company in a research report on Wednesday, April 3rd. Finally, Mizuho set a $67.00 target price on Walgreens Boots Alliance and gave the company a “hold” rating in a research report on Thursday, March 28th. Five research analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have given a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $68.50.
In related news, COO Ornella Barra acquired 18,000 shares of the stock in a transaction dated Wednesday, April 3rd. The stock was purchased at an average cost of $54.56 per share, with a total value of $982,080.00. Following the completion of the purchase, the chief operating officer now directly owns 26,425 shares in the company, valued at approximately $1,441,748. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Corporate insiders own 15.73% of the company’s stock.
Walgreens Boots Alliance stock traded down $0.52 during midday trading on Wednesday, reaching $54.32. The stock had a trading volume of 2,366,565 shares, compared to its average volume of 8,730,617. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.78 and a quick ratio of 0.38. The firm has a market capitalization of $50.14 billion, a price-to-earnings ratio of 9.02, a PEG ratio of 1.11 and a beta of 0.86. Walgreens Boots Alliance Inc has a 12 month low of $53.32 and a 12 month high of $86.31.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Tuesday, April 2nd. The pharmacy operator reported $1.64 EPS for the quarter, missing the consensus estimate of $1.70 by ($0.06). The company had revenue of $34.53 billion during the quarter, compared to analysts’ expectations of $34.57 billion. Walgreens Boots Alliance had a return on equity of 22.00% and a net margin of 3.77%. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period last year, the company earned $1.73 earnings per share. On average, sell-side analysts expect that Walgreens Boots Alliance Inc will post 5.99 EPS for the current year.
ILLEGAL ACTIVITY WARNING: This article was originally published by The Lincolnian Online and is the property of of The Lincolnian Online. If you are viewing this article on another publication, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The original version of this article can be accessed at https://www.thelincolnianonline.com/2019/04/17/gantzert-investment-co-llc-adv-buys-365-shares-of-walgreens-boots-alliance-inc-wba.html.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Article: How analysts view the yield curve
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.